Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | FDPS | P14324 | 6/20 | 0.41 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 3/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10534626 | 0.91 | SMPD1 (0.50) | FDPSSMPD1TRPM8S1PR2S1PR1 | |
| SCHEMBL10536255 | 0.86 | FDPS (0.37) | CYP3A4L3MBTL1FDPSSMPD1TSHR | |
| SCHEMBL11587211 | 0.83 | CYP3A4 (0.48) | CYP3A4L3MBTL1SMPD1TSHR | |
| SCHEMBL4669704 | 0.83 | SMPD1 (0.55) | FDPSSMPD1S1PR2S1PR1S1PR3 | |
| SCHEMBL27759001 | 0.81 | SMPD1 (0.48) | FDPSSMPD1S1PR2S1PR1S1PR3 | |
| SCHEMBL29288454 | 0.79 | FDPS (0.45) | CYP3A4L3MBTL1FDPSSMPD1S1PR2 | |
| SCHEMBL11585590 | 0.79 | CYP3A4 (0.44) | CYP3A4L3MBTL1FDPSSMPD1TSHR | |
| SCHEMBL27447919 | 0.78 | L3MBTL1 (0.41) | L3MBTL1 | |
| SCHEMBL9723212 | 0.77 | — | — | |
| SCHEMBL27727331 | 0.77 | FDPS (0.42) | FDPSSMPD1S1PR2S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1907518-A1 | LUBRICANT OIL FOR A REFRIGERATION MACHINE, LUBRICANT COMPOSITION AND REFRIGERATION MACHINE AND SYSTEM | WHIRLPOOL S.A. (BR) | 2008-04-09 | — | — | EP | disclosed |
| EP-1345915-B1 | IMPROVED PROCESS FOR THE PREPARATION OF WATER-SOLUBLE O-PHOSPHONOOXYMETHYL PRODRUGS | EISAI CO LTD (JP) | 2007-01-31 | — | — | EP | disclosed |
| WO-2007003024-A1 | LUBRICANT OIL FOR A REFRIGERATION MACHINE, LUBRICANT COMPOSITION AND REFRIGERATION MACHINE AND SYSTEM | WHIRLPOOL S.A. (BR) | 2007-01-11 | — | — | WO | disclosed |
| EP-1345915-A4 | IMPROVED PROCESS FOR WATER SOLUBLE AZOLE COMPOUNDS | BRISTOL MYERS SQUIBB CO (US) | 2005-08-03 | — | — | EP | disclosed |
| EP-1284737-B1 | WATER SOLUBLE PRODRUGS OF AZOLE COMPOUNDS | EISAI CO LTD (JP) | 2005-08-03 | — | — | EP | disclosed |
| EP-1345915-A1 | IMPROVED PROCESS FOR WATER SOLUBLE AZOLE COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-09-24 | — | — | EP | disclosed |
| EP-1284737-A4 | WATER SOLUBLE PRODRUGS OF AZOLE COMPOUNDS | BRISTOL MYERS SQUIBB CO (US) | 2003-03-19 | — | — | EP | disclosed |
| EP-1284737-A1 | WATER SOLUBLE PRODRUGS OF AZOLE COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-02-26 | — | — | EP | disclosed |
| US-6448401-B1 | REACTING A TRIAZOLE ANTIFUNGAL COMPOUND CONTAINING A SECONDARY OR TERTIARY HYDROXYL GROUP WITH A PROTECTED MONOCHLOROMETHYL PHOSPHATE; IODIDE ION SOURCE; ORGANIC SOLVENT; BASE | BRISTOL-MYERS SQUIBB COMPANY | 2002-09-10 | — | — | US | disclosed |
| WO-2002042283-A1 | IMPROVED PROCESS FOR WATER SOLUBLE AZOLE COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-05-30 | — | — | WO | disclosed |
| US-20020062028-A1 | Process for water soluble azole compounds | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2002-05-23 | — | — | US | disclosed |
| US-6362172-B2 | (DIHYDROGEN PHOSPHONOXY)ALKYLOXY CONTAINING A TRIAZOLE DERIVATIVE USED AS ANTIFUNGAL AGENT | BRISTOL-MYERS SQUIBB COMPANY | 2002-03-26 | — | — | US | disclosed |
| US-20010041691-A1 | Water soluble prodrugs of azole compounds | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2001-11-15 | — | — | US | disclosed |
| WO-2001052852-A1 | WATER SOLUBLE PRODRUGS OF AZOLE COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-07-26 | — | — | WO | disclosed |
| US-4604409-A | Polyamide-imide foams and methods of making same | IMI-TECH CORPORATION, ELK GROVE, ILL. A CORP. OF | 1986-08-05 | — | — | US | disclosed |
| US-4585805-A | Polyamide-imide foams and methods of making same | IMI-TECH CORPORATION, ELK GROVE, ILL. A CORP. OF | 1986-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010041691-A1 | Water soluble prodrugs of azole compounds | CYP51A1, ERG28, CYP7A1 | CYP3A4 16/4885L3MBTL1 2335/4885FDPS 702/4885 |
| US-20020062028-A1 | Process for water soluble azole compounds | CYP51A1, ERG28, CYP7A1 | CYP3A4 6/4885L3MBTL1 3869/4885FDPS 423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.